In 188 patients aged ≥12 with transfusion-dependent thalassaemia, thalidomide 1 mg/kg/day was non-inferior to 2 mg/kg/day for reducing transfusion need at week 24 (response 67.1% vs 50.0%; 82.4% evaluated). 10.6% stopped for toxicity.
RCTn = 188
Kakkar et al. Efficacy and safety of thalidomide (1 vs 2 mg/kg per day) in transfusion-dependent thalassemia: a noninferiority trial